Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-tumour immune responses to modified self-epitopes

Anti-tumour immune responses to modified self-epitopes

US Patent 11382985 · Granted Jul 12, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Epitopes2025
Epitopes2025
Anti-tumour response to modified self-epitopes2025
Anti-tumour response to modified self-epitopes2025
Anti-tumour immune responses to modified self-epitopes2020
Anti-tumour immune responses to modified self-epitopes2020
Anti-tumour immune responses to modified self-epitopes2020
Anti-tumour response to modified self-epitopes2019
Anti-tumour response to modified self-epitopes2019
Nucleic acids encoding antibodies or portions thereof comprising a heterologous 2014
Monoclonal antibody SC104 and derivative thereof specifically binding to a sialy2013
Binding member which binds to both lewis-Y and lewis-B haptens, and its use for 2012